ARMATA PHARMACEUTICALS, INC. Temporary Equity, Liquidation Preference
ARMATA PHARMACEUTICALS, INC. (ARMP) had Temporary Equity, Liquidation Preference of $0 as of 2016-12-31, per its 10-K filed 2017-03-27.
Discontinued › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2017-03-27
- 2016-12-31: Temporary Equity, Liquidation Preference $0.00.
- 2016-09-30: Temporary Equity, Liquidation Preference $0.00.
- 2016-06-30: Temporary Equity, Liquidation Preference $0.00.
- 2016-03-31: Temporary Equity, Liquidation Preference $13.71M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-27 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-10 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-15 |
| 2016-03-31 | $13.71M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $13.38M 10-K · filed 2017-03-27 |
| 2015-09-30 | $13.07M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $14.05M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $14.38M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $14.04M 10-K · filed 2016-03-30 |
| 2013-12-31 | $13.02M 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |